EEII AG

  • WKN: 940179
  • ISIN: CH0007162958
  • Land: Schweiz

Nachricht vom 12.12.2016 | 17:38

EEII AG: Appointment of new CEO and new Advisor

EEII AG / Key word(s): Change of Personnel/Miscellaneous

12-Dec-2016 / 17:38 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR


Ad-hoc Information: Appointment of new CEO and new Advisor

Zug, December 12, 2016

EEII AG announces that Mr. Andres Heusser, CEO of EEII AG, will resign from his position effective 31st December, 2016 and will be replaced by Mr. Marcus H. Bühler, Member of the Board of Weissenstein & Partner AG, Zürich. Weissenstein & Partner will also act as EEII's Advisor starting January 1st, 2017.

EEII welcomes Marcus H. Bühler and Weissenstein & Partner to their new positions, and expresses its sincere thanks to Andres Heusser who has worked for the Company in various capacities since 2008 and as its CEO since 2014, and to AIL Structured Finance AG who has served as the Company's Advisor since 2008, for their many years of outstanding and dedicated services to the Company.

For questions please contact:

Mr. Victor L. Gnehm (Phone: +41-41-723-1040).
EEII is listed on the Swiss Exchange (SIX) (Bloomberg: EEII SW Equity).



End of ad hoc announcement

show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Infineon Technologies AG: Aufsichtsrat beruft Jochen Hanebeck zum Nachfolger von Dr. Reinhard Ploss als Vorstandsvorsitzenden von Infineon

25. November 2021, 17:45

Aktuelle Research-Studie

3U HOLDING AG

Original-Research: 3U HOLDING AG (von GSC Research GmbH): Halten

26. November 2021